More Articles

IMS Health enlisted as information provider for drug shortages Pharma News | Posted 18/05/2012

The Generic Pharmaceutical Association (GPhA) announced on 19 April 2012 that it had selected IMS Health (IMS) to serve as the Independent Third Party in the Accelerated Recovery Initiative (ARI),...

Biosimilars approved and marketed in Belgium Biosimilars/General | Posted 18/05/2012

Last updated: 18 May 2012 The Federal Agency for Medicines and Health Products (FAMHP), formerly the Directorate-General for Medicinal Products of the Federal Public Service (FPS) Public Healt...

Daiichi Sankyo and Coherus BioSciences make biosimilars deal Biosimilars/News | Posted 18/05/2012

Coherus BioSciences and Daiichi Sankyo announced on 7 May 2012 that the two companies had made an exclusive agreement to develop and commercialise biosimilars of etanercept and rituximab in certain...

FDA says efforts to prevent drug shortages are working Pharma News | Posted 11/05/2012

FDA Commissioner Ms Margaret Hamburg has reported that the FDA’s office of drug shortages has made progress in preventing drug shortages and working with industry to provide advanced warning when t...

Can generic competition succeed at reducing cost of atorvastatin? Generics/Research | Posted 11/05/2012

The generic form of the cholesterol-lowering drug Lipitor (atorvastatin) has the potential for significant cost savings for payers following its introduction in November 2011. However, ‘aggressive...

Biosimilar filgrastim provides cost savings for treating febrile neutropenia Biosimilars/Research | Posted 11/05/2012

Professor Aapro and co-authors have performed a cost-efficiency analysis for the three most common granulocyte colony-stimulating factors (G-CSF) products used to treat febrile neutropenia: filgras...

Also noted on biosimilars: 11 May 2012 Biosimilars/General | Posted 11/05/2012

Sandoz testimony at FDA hearing on biosimilars will emphasise need for consistent regulatory standards across all biologicalsSandoz announced on 9 May 2012 that Dr Mark McCamish, Head of Global Bi...

Australia cuts prices of 13 more drugs on PBS Policies & Legislation | Posted 11/05/2012

Thirteen medicines on the Pharmaceutical Benefits Scheme (PBS), accounting for more than 200 brands, will take price cuts of between 11% and 77% from 1 August 2012 as part of the ongoing price disc...